Post-menopausal women with rheumatoid arthritis who are treated with raloxifene or alendronate or glucocorticoids have lower serum undercarboxylated osteocalcin levels

Journal of Endocrinological Investigation

Volumn 35, Issue 7, 2012, Pages 661-664

  Mokuda, S ^a   Okuda, Y ^a   Onishi, M ^a   Sawada, N ^a   Matoba, K ^a   Yamada, A ^a   Jouyama, K ^a   Takasugi, K ^a  

^a Dohgo Spa Hospital   (Japan)

Author keywords

Bone resorption inhibitor; Glucocorticoid induced osteoporosis; Rheumatoid arthritis; Undercarboxylated osteocalcin

Indexed keywords

ALENDRONIC ACID; ALKALINE PHOSPHATASE; METHOTREXATE; OSTEOCALCIN; PREDNISOLONE; RALOXIFENE; STROMELYSIN; UNCLASSIFIED DRUG; UNDERCARBOXYLATED OSTEOCALCIN;

AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CARBOXYLATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OSTEOLYSIS; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; RISK FACTOR;

AGED; AGED, 80 AND OVER; ALENDRONATE; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY CONSERVATION AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; GLUCOCORTICOIDS; HUMANS; MIDDLE AGED; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; RALOXIFENE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VITAMIN K DEFICIENCY;

EID: 84865778155     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7971     Document Type: Article

References (17)

1. Booth SL, Tucker KL, Chen H, et al. Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am J Clin Nutr 2000, 71: 1201-8.
2. Yaegashi Y, Onoda T, Tanno K, Kuribayashi T, Sakata K, Orimo H. Association of hip fracture incidence and intake of calcium, magnesium, vitamin D, and vitamin K. Eur J Epidemiol 2008, 23: 219-25.
3. Price PA. Vitamin K-dependent formation of bone Gla protein (osteocalcin) and its function. Vitam Horm 1985, 42: 65-108.
4. Vergnaud P, Garnero P, Meunier PJ, Bréart G, Kamihagi K, Delmas PD. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J Clin Endocrinol Metab 1997, 82: 719-24.
5. Shiraki M. Examination of clinical utility of serum ucOC measurement kit with the electrochemiluminescent immunoassay. Medicine and pharmacology 2007, 57: 537-46. [In Japanese]
6. Hirao M, Hashimoto J, Ando W, Ono T, Yoshikawa H. Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K2 in postmenopausal women. J Bone Miner Metab 2008, 26: 260-4.
7. Hozuki T, Imai T, Tsuda E, et al. Response of serum carboxylated and undercarboxylated osteocalcin to risedronate monotherapy and combined therapy with vitamin K(2) in corticosteroid-treated patients: a pilot study. Intern Med 2010, 49: 371-6.
8. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31: 315-24.
9. DAS-SCORE.NL. Home of the DAS: Disease activity score in rheumatoid arthritis. Available at: http://www.das-score.nl/
10. Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993, 8: 1137-48.
11. Shiraki M, Yamazaki Y, Shiraki Y, Hosoi T, Tsugawa N, Okano T. High level of serum undercarboxylated osteocalcin in patients with incident fractures during bisphosphonate treatment. J Bone Miner Metab 2010, 28: 578-84.
12. Roux C. Osteoporosis in inflammatory joint diseases. Osteoporos Int 2010, 22: 421-33.
13. Momohara S, Okamoto H, Yago T, et al. The study of bone mineral density and bone turnover markers in postmenopausal women with active rheumatoid arthritis. Mod Rheumatol 2005, 15: 410-4.
14. Aonuma H, Miyakoshi N, Hongo M, Kasukawa Y, Shimada Y. Low serum levels of undercarboxylated osteocalcin in postmenopausal osteoporotic women receiving an inhibitor of bone resorption. Tohoku J Exp Med 2009, 218: 201-5.
15. Kanazawa I, Yamaguchi T, Yamauchi M, et al. Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporos Int 2011, 22: 187-94.
16. Canalis E, Mazziotti G, Giustina A, Bilezikian JP. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int 2007, 18: 1319-28.
17. Leclerc N, Noh T, Khokhar A, Smith E, Frenkel B. Glucocorticoids inhibit osteocalcin transcription in osteoblasts by suppressing Egr2/Krox20-binding enhancer. Arthritis Rheum 2005, 52: 929-39.